Payne, S. N., Maher, M. E., Tran, N. H., Van De Hey, D. R., Foley, T. M., Yueh, A. E., . . . Deming, D. A. (2015). PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors. Oncogenesis.
Styl ChicagoPayne, S N., et al. "PIK3CA Mutations Can Initiate Pancreatic Tumorigenesis and Are Targetable With PI3K Inhibitors." Oncogenesis 2015.
Citace podle MLAPayne, S N., et al. "PIK3CA Mutations Can Initiate Pancreatic Tumorigenesis and Are Targetable With PI3K Inhibitors." Oncogenesis 2015.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..